🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

70+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 20 of 70 recruiting trials for “Autoimmune thrombocytopenia

Phase 1, PHASE2RecruitingNCT07043946

A Phase 1b/2a Study of Budoprutug in Subjects With Immune Thrombocytopenia (ITP)

👨‍⚕️ Study Director, Climb Bio, Inc.📍 20 sites📅 Started Jun 2025View details ↗
Phase 2RecruitingNCT06992128

Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial

🏥 Institute of Hematology & Blood Diseases Hospital, China📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06929299

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

👨‍⚕️ Lei Zhang, M.D., Hospital of Hematology, Chinese Academy of Medical Sciences📍 7 sites📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06853444

A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia

👨‍⚕️ Ming Hou, PhD, Qilu Hospital of Shandong University📍 1 site📅 Started May 2025View details ↗
Phase 3RecruitingNCT06900920

A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia

🏥 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.📍 53 sites📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06880081

Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)

👨‍⚕️ Lei Zhang, Chinese Academy of Medical Sciences📍 5 sites📅 Started Mar 2025View details ↗
Phase 2RecruitingNCT06799611

An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune Thrombocytopenia

👨‍⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Mar 2025View details ↗
Phase 1RecruitingNCT06826430

Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia

👨‍⚕️ Mengtao Li, Dr., Peking Union Medical College📍 1 site📅 Started Mar 2025View details ↗
Phase 3RecruitingNCT06722235

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

👨‍⚕️ Study Director, Takeda📍 110 sites📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06531018

Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.

👨‍⚕️ Md Manirul Islam, MBBS,FCPS, Dhaka Medical College📍 1 site📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06776510

A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia

👨‍⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Jan 2025View details ↗
NARecruitingNCT06813157

Mesenchymal Stem Cells in the Treatment of Refractory Primary Immune Thrombocytopenia

🏥 Guangzhou Bio-gene Technology Co., Ltd📍 1 site📅 Started Jan 2025View details ↗
Phase 1, PHASE2RecruitingNCT07017725

A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune Thrombocytopenia

👨‍⚕️ Junping Chen, CASI pharmaceutical, Inc📍 6 sites📅 Started Jan 2025View details ↗
NARecruitingNCT07068126

Management of Children With Persistent ITP, A Novel Approach

👨‍⚕️ Mervat M A Youssef, Assistant Professor, Assiut University📍 3 sites📅 Started Jan 2025View details ↗
Phase 2RecruitingNCT06686927

Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP

🏥 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology📍 1 site📅 Started Nov 2024View details ↗
NARecruitingNCT06715215

Role of Acute Phase Proteins In Diagnosis of Immune Thrombocytopenia

🏥 Sohag University📍 1 site📅 Started Nov 2024View details ↗
EARLY_Phase 1RecruitingNCT06888960

Safety Study of CC312 in Autoimmune Disease Patients

🏥 CytoCares Inc📍 1 site📅 Started Nov 2024View details ↗
Phase 3RecruitingNCT06544499

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

🏥 argenx📍 94 sites📅 Started Oct 2024View details ↗
RecruitingNCT06919341

RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia

🏥 Fundación Española de Hematología y Hemoterapía📍 36 sites📅 Started Sep 2024View details ↗
RecruitingNCT06817395

Cognitive Dysfunction in Chronic and Persistent Immune Thrombocytopenia

🏥 Massachusetts General Hospital📍 1 site📅 Started Sep 2024View details ↗
← PreviousPage 2 of 4Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →